Sastasundar Vent Peer Comparison
NSE: SASTASUNDR | BSE: 533259
₹274.85
As on 18-Nov-2026IST
Market cap
₹878 Cr
Revenue (TTM)
₹1,650 Cr
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
878 | 38,579 | 32,976 | 31,765 | 15,821 |
Revenue (₹ Cr) |
1,650 | 5,053 | 3,034 | 4,596 | 911 |
Net Profit (₹ Cr) |
-23.34 | 613.08 | 588.10 | 193.80 | 203.68 |
Net Margin (%) |
-1.37 | 11.89 | 18.68 | 4.17 | 21.86 |
RoE (%) |
-2.80 | 15.63 | 23.05 | 6.86 | 20.22 |
Price to Earnings |
-- | 62.38 | 56.51 | 149.55 | 77.68 |
Price-To-Book |
1.39 | 8.92 | 12.02 | 8.08 | 14.96 |
Income Statement (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Operating Income
|
1,650.45 | 5,053.19 | 3,034.10 | 4,596.20 | 910.96 |
|
Other Income
|
50.60 | 104.30 | 114.60 | 49.90 | 20.98 |
|
Total Income
|
1,377.54 | 4,514.67 | 2,864.18 | 3,930.80 | 835.00 |
|
Interest Expense
|
2.14 | 102.98 | 26.60 | 273.80 | 40.30 |
|
PBT & Exceptional Items
|
-19.63 | 851.75 | 803.80 | 280.00 | 272.85 |
|
Operating Expenses
|
1,716.63 | 3,935.28 | 2,140.30 | 3,707.10 | 518.10 |
|
Exceptional Income/Expenses
|
-0.96 | -36.60 | -30.10 | 2.30 | 0.00 |
|
Profit before Tax
|
-27.17 | 815.15 | 773.70 | 282.30 | 272.85 |
|
Taxes
|
-3.83 | 202.07 | 185.60 | 88.50 | 69.17 |
|
Profit after Tax
|
-23.34 | 613.08 | 588.10 | 193.80 | 203.68 |
|
Minority Interest
|
4.80 | 5.33 | -4.50 | 15.40 | 0.00 |
|
Share of Associate
|
0.00 | 0.00 | -0.10 | 3.20 | 0.00 |
|
Consolidated Profit
|
-18.54 | 618.41 | 583.50 | 212.40 | 203.68 |
Liabilities (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
632.60 | 4,323.39 | 2,744.50 | 3,931.80 | 1,057.33 |
|
Minority Interest
|
4.80 | 5.33 | -4.50 | 15.40 | 0.00 |
|
Non-Current Liabilities
|
20.93 | 1,495.04 | 190.40 | 3,247.20 | 515.16 |
|
Current Liabilities
|
169.58 | 768.03 | 487.70 | 1,412.60 | 160.86 |
|
Total Liabilities
|
930.34 | 5,905.00 | 3,139.97 | 7,690.70 | 1,507.05 |
Assets (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
153.18 | 3,286.77 | 1,196.40 | 6,040.80 | 773.26 |
|
Current Assets
|
520.10 | 2,088.60 | 1,883.10 | 1,476.90 | 449.80 |
|
Total Assets
|
930.34 | 5,905.00 | 3,139.97 | 7,690.70 | 1,507.05 |
|
Contingent Liabilities
|
3.33 | 100.01 | 16.76 | 81.10 | 0.13 |
Cashflow (₹ Cr)
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-73.83 | 714.39 | 635.61 | 510.80 | 270.59 |
|
Cash Flow from Investing Activities
|
171.19 | -1,089.11 | -421.86 | -1,451.70 | -174.22 |
|
Cash from Financing Activities
|
-79.59 | 271.85 | -263.57 | 940.30 | -69.49 |
|
Net Cash Inflow / Outflow
|
17.77 | -102.87 | -49.83 | -0.60 | 26.88 |
Ratios
Profitability Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-0.21 | 19.38 | 29.56 | 11.51 | 30.28 |
|
ROE (%)
|
-2.80 | 15.63 | 23.05 | 6.86 | 20.22 |
|
ROA (%)
|
-2.39 | 10.20 | 18.33 | 2.49 | 13.04 |
|
EBIT Margin (%)
|
-4.52 | 16.83 | 23.59 | 10.96 | 32.07 |
|
Net Margin (%)
|
-1.37 | 11.89 | 18.68 | 4.17 | 21.86 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
41.44 | 26.18 | 16.71 | 35.12 | 24.47 |
|
EBIT Growth (%)
|
-5.61 | 16.83 | 20.83 | -10.81 | 38.42 |
|
Net Profit Growth (%)
|
-106.59 | 9.16 | 8.95 | -45.50 | 33.97 |
|
EPS Growth (%)
|
-4,264.59 | 13.12 | -43.47 | -36.93 | 33.02 |
|
Book Value Growth (%)
|
-4.33 | 16.51 | 15.41 | 5.13 | 21.86 |
Valuation Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-49.27 | 59.58 | 54.41 | 146.30 | 77.59 |
|
Price / Book Value
|
1.39 | 8.92 | 12.02 | 8.08 | 14.96 |
|
Dividend Yield (%)
|
0.00 | 0.03 | 1.04 | 0.00 | 0.13 |
|
EV/EBITDA
|
-11.56 | 34.06 | 35.40 | 39.27 | 39.56 |
|
Market Cap (₹ Cr)
|
831.01 | 25,841.07 | 22,015.15 | 24,901.98 | 8,864.05 |
Solvency Ratios
| Sastasundar Vent | Global Health | Dr. Lal Pathlabs | Krishna Institute | Vijaya Diagno | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.15 | 0.00 | 0.49 | 0.00 |
|
Short term debt to equity ratio
|
0.03 | -- | -- | 0.15 | -- |
|
Current Ratio
|
3.07 | 2.72 | 3.86 | 1.05 | 2.80 |
|
Quick Ratio
|
3.07 | 2.60 | 3.75 | 0.96 | 2.74 |
|
Interest Coverage
|
-11.73 | 8.92 | 30.09 | 2.03 | 7.77 |